Similar live GeM bids
HomeGeM BidsMedical EquipmentGEM/2026/B/7567656
Medical EquipmentGoodsDefenceWorks

Procurement of Propofol, Bupivacaine HCl, and Lignocaine HCl Jelly for Indian Army medical requirements

Indian Army invited bids on GeM for "Procurement of Propofol, Bupivacaine HCl, and Lignocaine HCl Jelly for Indian Army medical requirements" — a Medical Equipment works procurement. Bids close on 03 Jul 2026, 19:30. Quantity 159674. Bid number GEM/2026/B/7567656.
Ministry of Defence » Department of Military Affairs » Indian Army · Bid GEM/2026/B/7567656
Est. value
Not disclosed
Bid closes
03 Jul 2026
15 days left
Quantity
159674
Status
Live

Bid document

Bid details are referenced from GeM (bidplus.gem.gov.in). Live bidding and authoritative documents remain on the official portal.

Complete bid details

Buyer & organisation
Ministry / StateMinistry of Defence
DepartmentDepartment of Military Affairs
OrganisationIndian Army
SectorDefence
Buyer typeCentral
Item & category
ItemPropofol 1 or 10 mg ml 20 ml Inj,Bupivacaine HCl 5mg ml heavy 4 ml Inj,Lignocaine HCl Jelly 2 Tube
CategoryMedical Equipment
Sub-categoryPharmaceuticals
TypeGoods
ProcurementWorks
Quantity159674
Reverse AuctionNo
Make-in-India pref.Yes
BiddingTwo-packet
Financials & eligibility
Estimated valueNot disclosed
Value tierNot disclosed
EMD requiredYes
ePBG requiredYes
Min. turnover1500000
Experience req.3 yrs
MSE-friendlyYes
Startup-friendlyYes
New-seller-friendlyYes
Installation req.No
Inspection req.No
CertificationsNone specified
Delivery
Delivery statesRajasthan
ScopeSingle-state

Frequently asked questions

What is this GeM bid for?
Indian Army floated this GeM bid for "Procurement of Propofol, Bupivacaine HCl, and Lignocaine HCl Jelly for Indian Army medical requirements" under Medical Equipment, procured as works.
What is the estimated value?
The value tier was not disclosed for this bid.
When does this bid close?
Bids close on 03 Jul 2026, 19:30.
Is it MSE / startup friendly?
MSE-friendly: Yes; Startup-friendly: Yes; New-seller-friendly: Yes.